Clinical Research Directory

Inclusion Criteria: * no contraindications to taking Osteogenon * a follow-up period of more than 3 months after treatment completion * complete medical and radiological records * a written informed consent * not taking any other medications that could affect bone tissue remodeling * not taking other medications that interact with Osteogenon * no other limb pathologies (inflammatory or neurogenic) * absence of comorbidities that could affect bone union Exclusion Criteria: * age under 18 years or over 85 years * hypersensitivity to the active ingredient or to any of the excipients * severe renal failure and dialysis therapy * hypercalcemia * hypercalciuria * calcium-based kidney stones or tissue calcifications * a follow-up period shorter than 3 months after treatment completion * a lack of informed consent * a lack of cooperation with the patient * absent or incomplete medical and radiological records * taking medications that could affect bone tissue remodeling * taking medications that may interact with Osteogenon (e.g. thiazide diuretics) * metabolic disorders * post-traumatic skeletal deformities * neuromuscular disorders * post-inflammatory deformities